SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Bolsa Mexicana de Valore Mexiko-Stadt
Börse Bolsa Mexicana de Valore Mexiko-Stadt
Symbol MRNA
MXN
  • Moderna Inc
    Börse Nasdaq
    ISIN US60770K1079 WKN: A2N9D9
    Symbol MRNA
  • Moderna
    Börse Börse Frankfurt
    ISIN US60770K1079 WKN: A2N9D9
    Symbol 0QF
    EUR
  • Moderna
    Börse Börse Berlin
    Symbol 0QF
    EUR
  • Moderna
    Börse Börse Stuttgart
    Symbol 0QF
    EUR
  • Moderna
    Börse Börse München
    Symbol 0QF
    EUR
  • Moderna
    Börse Börse Hamburg
    Symbol 0QF
    EUR
  • Moderna
    Börse Xetra Frankfurt
    Symbol 0QF
    EUR
  • Moderna
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol 0QF
    EUR
  • Moderna
    Börse Quotrix System der Börse Düsseldorf
    Symbol 0QF
    EUR
  • Moderna
    Börse Gettex System der Börse München
    Symbol 0QF
    EUR
  • Moderna
    Börse Börse Düsseldorf
    Symbol 0QF
    EUR
  • Moderna
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    Symbol MRNA
    MXN
  • Moderna, Inc.
    Börse BVMF
  • Moderna, Inc.
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
  • Moderna, Inc.
    Börse London Stock Exchange
Symbol MRNA
Währung MXN
Börse Bolsa Mexicana de Valore Mexiko-Stadt Zeitzone: Europe/Berlin
Mitarbeiter 3.900

Moderna outperformed den DAX um +786 % vom 09.04.2019 bis 02.07.2021

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Moderna abonniert.

Aktionärsstruktur der Moderna

1.404 News & Informationen zur Moderna Aktie

  • Daimler, Biontech, Standard Lithium, Ethereum – ein Börsendienst, der “nah dran ist”
    feingold-research.com

  • Biontech, Valneva, Curevac, Standard Lithium – hier spielt die Musik für Anleger
    feingold-research.com

  • Biontech, Dynavax, Valneva – jetzt kommt Feuer rein
    feingold-research.com

  • Australia’s Covid Epicenter Sees Another Day of Record Cases
    bloombergquint.com

    Australia’s Covid Epicenter Sees Another Day of Record Cases

    (Bloomberg) —

    New South Wales, Australia’s most populous state, reported a record 1,533 new daily coronavirus cases, with the state’s creaking health system braced for a peak in hospitalizations in October.

  • Covid-19: FDA looks for Moderna booster shot data in weighing dose
    business-standard.com

    Covid-19: FDA looks for Moderna booster shot data in weighing dose

    Read more about Covid-19: FDA looks for Moderna booster shot data in weighing dose on Business Standard. Moderna announced Friday that it had 'completed' its submission of data to the Food and Drug Administration for authorization of boosters

  • U.S. COVID-19 booster shot campaign to start with only Pfizer - source
    financialpost.com

    U.S. COVID-19 booster shot campaign to start with only Pfizer – source

    WASHINGTON — A White House plan to offer COVID-19 booster shots will most likely start this month only with the vaccine made by Pfizer Inc and BioNTech , a…

  • Florida Deaths at Record; Kids Hit by Delta Wave: Virus Update
    financialpost.com

  • Moderna vs. Inovio Pharmaceuticals: Which Coronavirus Vaccine Stock is a Better Investment? By StockNews
    investing.com

    Moderna vs. Inovio Pharmaceuticals: Which Coronavirus Vaccine Stock is a Better Investment? By StockNews

    Moderna vs. Inovio Pharmaceuticals: Which Coronavirus Vaccine Stock is a Better Investment?

  • Moderna seeks EU authorization for COVID-19 vaccine booster dose
    financialpost.com

    Moderna seeks EU authorization for COVID-19 vaccine booster dose

    Moderna Inc said on Friday it had asked the EU drugs regulator for conditional approval of a booster shot of its COVID-19 vaccine at a 50 microgram dose.

  • Moderna : submits application for COVID-19 booster dose to EU regulator
    marketscreener.com

    Moderna : submits application for COVID-19 booster dose to EU regulator

    Moderna Inc said on Friday it
    has submitted for conditional approval of a booster dose of its
    COVID-19 vaccine at a 50 microgram dose level to the EU drugs
    regulator.
    (Reporting by Manojna Maddipatla… | September 3, 2021

  • Moderna And Nvidia Lead The Nasdaq-100
    benzinga.com

    Moderna And Nvidia Lead The Nasdaq-100

    U.S. indices had a mixed day of trading Friday as investors weigh an increase in COVID-19 deaths nationwide. The SPDR S&P 500 ETF Trust (NASDAQ: SPY) …

  • ‘Stocks Love Stimulus’: Nasdaq Posts New Record High As ‘Worrisome’ Jobs Report Boosts Relief Prospects
    forbes.com

    ‘Stocks Love Stimulus’: Nasdaq Posts New Record High As ‘Worrisome’ Jobs Report Boosts Relief Prospects

    Despite the job market posting its worst month since January, tech stocks surged to new highs on Friday.

  • Moderna Announces Submission Of Data To European Medicines Agency For Its COVID-19 Vaccine Booster
    thestreet.com

    Moderna Announces Submission Of Data To European Medicines Agency For Its COVID-19 Vaccine Booster

    Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has submitted for a

  • Covid-19 Vaccine Booster Launch Could Be Delayed for Many
    online.wsj.com

    Covid-19 Vaccine Booster Launch Could Be Delayed for Many

    Federal health officials are asking the White House to push back the start of a planned booster campaign, at least for the Moderna and Johnson & Johnson vaccines, people familiar with the discussions said.

  • Moderna Inc (MRNA) CEO Stephane Bancel Sold $7.4 million of Shares
    gurufocus.com

    Moderna Inc (MRNA) CEO Stephane Bancel Sold $7.4 million of Shares

    GuruFocus Article or News written by insider and the topic is about:

  • Moderna says FDA submission for its COVID-19 booster shot is complete (NASDAQ:MRNA)
    seekingalpha.com

    Moderna says FDA submission for its COVID-19 booster shot is complete (NASDAQ:MRNA)

    Moderna (MRNA) says that the company has completed the submission to the FDA seeking a review of its booster COVID-19 shot

  • Ocugen Stock Seems Unattractive with Limited Market Opportunity By TipRanks
    investing.com

    Ocugen Stock Seems Unattractive with Limited Market Opportunity By TipRanks

    Ocugen Stock Seems Unattractive with Limited Market Opportunity

  • 10 Best-Performing Countries for COVID-19 Vaccinations
    insidermonkey.com

    10 Best-Performing Countries for COVID-19 Vaccinations

    In this article, we will list the 10 best-performing countries for COVID-19 vaccinations.

  • What’s New With Novavax Stock?
    forbes.com

    What’s New With Novavax Stock?

    Novavax stock rallied by about 5% over the last week, outperforming the S&P 500 which gained less than 1% over the same period. Although Novavax doesn’t have a revenue-generating product just yet, with the company intending to file for Emergency Use Authorization for its Covid-19 vaccine in the U.K.

  • Rich Asians jump booster shot queue, put 'entire community at risk'
    business-standard.com

    Rich Asians jump booster shot queue, put 'entire community at risk'

    Read more about Rich Asians jump booster shot queue, put 'entire community at risk' on Business Standard. The growing trend in countries like Indonesia, Thailand and the Philippines is worsening inequities at a time when they are grappling with vaccine shortages

  • Moderna To Present At Upcoming Investor Conferences In September 2021
    thestreet.com

    Moderna To Present At Upcoming Investor Conferences In September 2021

    Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the

  • FDA committee to discuss COVID-19 booster shots
    marketwatch.com

    FDA committee to discuss COVID-19 booster shots

    An influential Food and Drug Administration advisory committee plans to meet Sept. 17 to discuss extra doses of the COVID-19 vaccines, including the…

  • European Officials Don't See Need for Covid Vaccine Booster
    thestreet.com

    European Officials Don't See Need for Covid Vaccine Booster

    There is no urgent need for booster doses of vaccines to fully vaccinated individuals in the general population, a report said.

  • Moderna Asks FDA to Approve Covid Booster Shot
    thestreet.com

    Moderna Asks FDA to Approve Covid Booster Shot

    Moderna shares rose Thursday after the company asked the FDA to approve use of a third, or booster, shot of its Covid-19 vaccine.

  • Moderna says covid-19 vaccine contaminant in Japan was stainless steel, sees no safety issue
    livemint.com

    Moderna says covid-19 vaccine contaminant in Japan was stainless steel, sees no safety issue

    Japan last week recalled three lots of the Moderna vaccine containing a total of 1.63 million doses

  • +++Börsen-Ticker+++ - Versicherer bremsen Schweizer Börse
    cash.ch

    +++Börsen-Ticker+++ – Versicherer bremsen Schweizer Börse

    An der Schweizer Börse haben die Anleger am Donnerstag die Füsse stillgehalten.

  • FDA resignations over White House booster shot guidance a 'mess for administration'
    news.google.com

    FDA resignations over White House booster shot guidance a 'mess for administration'

    Reports that Food and Drug Administration officials plan to step down over the White House’s COVID-19 booster shot guidance have created a “mess” for the Biden administration, according to Dr. Mark Siegel.

  • MRNA Emerges As The Newest & Most Potent Technology In Medicine. Market To Witness Robust Growth Far Beyond The COVID-19 Pandemic
    thestreet.com

    MRNA Emerges As The Newest & Most Potent Technology In Medicine. Market To Witness Robust Growth Far Beyond The COVID-19 Pandemic

    SAN FRANCISCO, Sept. 2, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • These Top Stocks Are Leading The S&P 500 To New Highs In 2021
    forbes.com

    These Top Stocks Are Leading The S&P 500 To New Highs In 2021

    Shares of vaccine-maker Moderna have skyrocketed more than 270% this year.

  • Moderna COVID-19 booster strategy triggers debate on dose level (NASDAQ:MRNA)
    seekingalpha.com

    Moderna COVID-19 booster strategy triggers debate on dose level (NASDAQ:MRNA)

    While Moderna (MRNA) made submissions to the FDA to support a booster dose of its COVID-19 vaccine at half the dosage in the first two shots, some in the government are said to be…

  • European regulator sees ‘no urgent need’ for COVID-19 boosters, calls for greater emphasis on getting unvaccinated to get shots
    marketwatch.com

    European regulator sees ‘no urgent need’ for COVID-19 boosters, calls for greater emphasis on getting unvaccinated to get shots

    The European Medicines Agency said Thursday there is no “urgent need” for COVID-19 booster shots for fully vaccinated people and suggested instead the…

  • Netflix Ranked Among Today’s Trending Stocks As We Kick Off September Trading Month
    forbes.com

    Netflix Ranked Among Today’s Trending Stocks As We Kick Off September Trading Month

    Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified Netflix among others.

  • Moderna (MRNA) Gives First COVID Jab Booster Data to the FDA
    zacks.com

    Moderna (MRNA) Gives First COVID Jab Booster Data to the FDA

    Moderna's (MRNA) booster dose of COVID-19 vaccine elicits antibody levels that were much higher than that seen after the two-dose primary schedule.

  • Aktien New York Ausblick: Freundlich - Warten auf Jobbericht
    finanzen.net

    Aktien New York Ausblick: Freundlich – Warten auf Jobbericht

    Aktien New York Ausblick: Freundlich – Warten auf Jobbericht | Nachricht | finanzen.net

  • Trading Activity May Remain Subdued Ahead Of Monthly Jobs Report
    rttnews.com

    Trading Activity May Remain Subdued Ahead Of Monthly Jobs Report

    The major U.S. index futures are currently pointing to a higher open on Thursday, although trading activity may remain relatively subdued following the lackluster performance seen over the two previous sessions.

  • COVID-19 vaccine: Moderna, Japan partner recall 1.6 million doses
    businesstoday.in

    COVID-19 vaccine: Moderna, Japan partner recall 1.6 million doses

    The two companies said an investigation at a Spanish factory that produced the vials in question concluded the contamination occurred in the process of putting stops on the vials

  • Asian Shares Mixed Ahead Of US Jobs Report
    rttnews.com

    Asian Shares Mixed Ahead Of US Jobs Report

    Asian stocks ended mixed on Thursday as caution prevailed ahead of the release of the U.S Labor Department's closely watched monthly jobs report on Friday, which could shed more light on the Fed's tapering strategy.

  • Asian Shares Mixed Ahead Of U.S. Jobs Report
    rttnews.com

    Asian Shares Mixed Ahead Of U.S. Jobs Report

    Asian stocks ended mixed on Thursday as caution prevailed ahead of the release of the U.S Labor Department's closely watched monthly jobs report on Friday, which could shed more light on the Federal Reserve's tapering strategy.

  • Helped by TSMC and Foxconn, BioNTech vaccines finally reach Taiwan
    financialpost.com

    Helped by TSMC and Foxconn, BioNTech vaccines finally reach Taiwan

    TAOYUAN — The first batch of BioNTech SE’s COVID-19 vaccine arrived in Taiwan on Thursday, helped by the involvement of two of the world’s most important tech…

  • Helped by tech giants, BioNTech vaccines finally reach Taiwan
    financialpost.com

    Helped by tech giants, BioNTech vaccines finally reach Taiwan

    TAOYUAN — The first batch of BioNTech SE’s COVID-19 vaccine arrived in Taiwan on Thursday, after months of heated political and diplomatic wrangling and helped…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Moderna Aktie

Das Unternehmen Moderna aus USA beschäftigt 3.900 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.

Die Moderna Aktie konnte seit dem 09.04.2019 eine Rendite von sage und schreibe 818% erwirtschaften.

Moderna ist in mehr als 39 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology  UCITS  ETF gewichtet Moderna mit 12,47% im ETF.

Entdecke die 6 ETFs in denen Moderna am höchsten gewichtet ist Insgesamt in 39 ETFs enthalten

Dir gefallen die Informationen zu Moderna?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Moderna?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Moderna?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Moderna?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic